MedPath

REGION VÄSTERBOTTEN

🇧🇪Belgium
Ownership
Private
Established
1863-01-01
Employees
-
Market Cap
-
Website
https://www.regionvasterbotten.se

Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life

Not yet recruiting
Conditions
Lichen Sclerosus
First Posted Date
2025-05-22
Last Posted Date
2025-05-22
Lead Sponsor
Region Västerbotten
Target Recruit Count
370
Registration Number
NCT06984263

Composed Abdominal Wall Analysis. Collecting Tissue and Blood From Patients Undergoing Elective Laparosopic Cholecystectomy. Objective to Describe the Normal Abdominal Wall

Conditions
Hernia
Abdominal Wall
First Posted Date
2024-12-04
Last Posted Date
2024-12-04
Lead Sponsor
Region Västerbotten
Target Recruit Count
40
Registration Number
NCT06717061
Locations
🇸🇪

Kirurgcentrum Västerbotten, Skellefteå, Sweden

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Phase 3
Recruiting
Conditions
Prostate Cancer
Interventions
Drug: [18F]PSMA-PET
Device: MRI sequences optimized for prostate cancer examinations
First Posted Date
2024-08-21
Last Posted Date
2025-03-04
Lead Sponsor
Region Västerbotten
Target Recruit Count
60
Registration Number
NCT06565247
Locations
🇸🇪

Region Skåne, Malmö, Sweden

🇸🇪

Region Västerbotten, Umeå, Sweden

Different Forms of OMT as Methods for Reducing Snoring and Mild to Moderate Sleep Apnea

Not Applicable
Conditions
Sleep Apnea, Obstructive
Snoring
Interventions
Behavioral: Grouptraining
Device: IQoro
Device: eXciteosa
First Posted Date
2024-03-26
Last Posted Date
2025-01-29
Lead Sponsor
Region Västerbotten
Target Recruit Count
141
Registration Number
NCT06330116
Locations
🇸🇪

Skåne University Hospital, Lund, Skåne, Sweden

🇩🇰

Zealand University Hospital, Köge, Sjaelland, Denmark

🇸🇪

Region Västerbotten, Umeå, Västerbotten, Sweden

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

Recruiting
Conditions
Epithelial Ovarian Cancer
Endometrial Cancer
Cervix Cancer
Interventions
Diagnostic Test: FDG-PET/CT and FDG-PET/MRI
First Posted Date
2023-05-12
Last Posted Date
2024-12-16
Lead Sponsor
Region Västerbotten
Target Recruit Count
120
Registration Number
NCT05855941
Locations
🇸🇪

Centre for Gynecology and Obstetrics, Umea University Hospital, Umea, Sweden

The Effect on Envelope of Motion in Asymptomatic Bruxers

Not Applicable
Recruiting
Conditions
Tooth Wear
Bruxism
Interventions
First Posted Date
2022-11-03
Last Posted Date
2023-05-03
Lead Sponsor
Region Västerbotten
Target Recruit Count
60
Registration Number
NCT05604729
Locations
🇸🇪

Norrlands universitetssjukhus, Umeå, Västerbotten, Sweden

Methotrexate in Patients with Early Rheumatoid Arthritis

Phase 4
Active, not recruiting
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2022-04-29
Last Posted Date
2025-01-14
Lead Sponsor
Region Västerbotten
Target Recruit Count
212
Registration Number
NCT05353829
Locations
🇸🇪

Region Sörmland, Eskilstuna, Sweden

🇸🇪

Region Dalarna, Falun, Sweden

🇸🇪

Region Gävleborg, Gävle, Sweden

and more 10 locations

Muscle Weakness Duration After Single Botulinum Toxin Injection in Masseter

Not Applicable
Completed
Conditions
Bite Force
Botulinum Toxins, Type A
Interventions
First Posted Date
2022-04-04
Last Posted Date
2023-05-03
Lead Sponsor
Region Västerbotten
Target Recruit Count
32
Registration Number
NCT05309564
Locations
🇸🇪

Norrlands universitetssjukhus, Umeå, Västerbotten, Sweden

A Mobile Application to Increase Physical Activity

Not Applicable
Conditions
Physical Activity
Interventions
Device: Physical activity mobile-application
First Posted Date
2019-04-24
Last Posted Date
2019-07-02
Lead Sponsor
Region Västerbotten
Target Recruit Count
4000
Registration Number
NCT03925363

FDG - PET / MRI in Patients With Rectal Cancer

Conditions
Rectal Cancer
Lymph Node Metastases
First Posted Date
2019-02-20
Last Posted Date
2019-02-20
Lead Sponsor
Region Västerbotten
Target Recruit Count
100
Registration Number
NCT03846882
Locations
🇸🇪

Department of Radology, Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath